Wu C C, Ho W L, Yeh D C, Huang C R, Liu T J, P'eng F K
Department of Surgery, Taichung Veterans General Hospital, Taiwan.
Surgery. 1996 Jul;120(1):34-9. doi: 10.1016/s0039-6060(96)80238-8.
Resection for hepatocellular carcinoma in patients with cirrhosis and impaired liver function is usually unjustified because of higher surgical risks and poorer long-term prognosis.
A retrospective comparison of the background and resectional results of patients with cirrhosis and hepatocellular carcinoma was carried out between those with preoperative indocyanine green 15-minute retention rate of 20% or greater (group A, impaired function group, n = 36) and those with indocyanine green 15-minute retention rate of 10% or less (group B, normal function group, n = 34).
The group A patients had significantly lower serum albumin level and higher serum bilirubin level, longer prothrombin time, higher incidence of associated esophageal varices, and poorer Child's classifications for cirrhosis. Although the tumor diameter in both groups was similar (A, 6.9 versus B, 7.1 cm; p = 0.94), the resected liver amount in group B was greater (227.4 versus 473.2 gm; p = 0.038) because of a greater extent of liver resection (p < 0.001) and a wider surgical margin (0.34 versus 1.85 cm; p < 0.0001). The amount of operative blood loss and blood transfusion, operative morbidity, and operative mortality were not different between the two groups. The pathologic characteristics and staging were also comparable. The 5-year disease-free and actuarial survival rates of groups A and B were 30.9% and 29.6% (p = 0.16) and 45.2% and 33.4% (p = 0.11), respectively.
If the amount of resected nontumorous liver parenchyma could be reduced, resection of hepatocellular carcinoma in selected patients with cirrhosis and impaired liver function is still justified in spite of a narrow surgical margin.
由于手术风险较高且长期预后较差,通常不主张对肝硬化及肝功能受损的肝细胞癌患者进行手术切除。
对术前吲哚菁绿15分钟潴留率为20%或更高的肝硬化合并肝细胞癌患者(A组,功能受损组,n = 36)和吲哚菁绿15分钟潴留率为10%或更低的患者(B组,功能正常组,n = 34)的背景和切除结果进行回顾性比较。
A组患者血清白蛋白水平显著较低,血清胆红素水平较高,凝血酶原时间较长,合并食管静脉曲张的发生率较高,肝硬化的Child分级较差。尽管两组的肿瘤直径相似(A组为6.9 cm,B组为7.1 cm;p = 0.94),但B组切除的肝组织量更大(分别为227.4 g和473.2 g;p = 0.038),这是因为肝切除范围更大(p < 0.001)且手术切缘更宽(分别为0.34 cm和1.85 cm;p < 0.0001)。两组的术中失血量、输血量、手术并发症发生率和手术死亡率并无差异。病理特征和分期也具有可比性。A组和B组的5年无病生存率和实际生存率分别为30.9%和29.6%(p = 0.16)以及45.2%和33.4%(p = 0.11)。
如果能够减少非肿瘤性肝实质的切除量,那么对于部分肝硬化及肝功能受损的肝细胞癌患者,尽管手术切缘较窄,进行手术切除仍是合理的。